🇺🇸 Immunoglobulin G in United States

25,404 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 4,296 reports (16.91%)
  2. Fatigue — 2,800 reports (11.02%)
  3. Covid-19 — 2,728 reports (10.74%)
  4. Headache — 2,518 reports (9.91%)
  5. Drug Ineffective — 2,387 reports (9.4%)
  6. Pneumonia — 2,300 reports (9.05%)
  7. Sinusitis — 2,286 reports (9%)
  8. Product Dose Omission Issue — 2,147 reports (8.45%)
  9. Inappropriate Schedule Of Product Administration — 2,137 reports (8.41%)
  10. Malaise — 1,805 reports (7.11%)

Source database →

Immunoglobulin G in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Immunoglobulin G approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Immunoglobulin G in United States?

Green Cross Corporation is the originator. The local marketing authorisation holder may differ — check the official source linked above.